NOVO NORDISK A S NVO (NYSE)

Among the sector activity stories for Thursday, July 3, from AP Financial News: NEW YORK (AP)--Shares of rental car companies fell Thursday as analysts and investors continued to w...READ MORE

(NEW YORK)Proposals for tougher heart-risk studies on new Type 2 diabetes drugs weighed heavy on shares of Amylin Pharmaceuticals Inc. and Novo Nordisk AS Thursday, since stricter regulation...READ MORE

(NEW YORK)Shares of Maxygen Inc. jumped Wednesday after the biotechnology company said it is selling its hemophilia treatment program to Bayer's health care division for $90 million, plus up...READ MORE

(WASHINGTON)Danish drugmaker Novo Nordisk AS spent $330,000 lobbying the U.S. government in the first quarter, according to a recent disclosure form. The company lobbied in favor of increased ...READ MORE

(NEW YORK)Shares of Novo Nordisk AS rose more than 3 percent Tuesday after a Goldman Sachs analyst upgraded the stock to "Buy" from "Neutral," saying the Danish drug maker is well-positioned...READ MORE

(NEW YORK)Shares of Emisphere Technologies Inc. rose Monday after the company said it signed a licensing deal worth at least $87 million with Novo Nordisk to develop diabetes treatments.READ MORE

(NEW YORK)Danish drug maker Novo Nordisk A/S said Monday patients treated with its diabetes drug liraglutide showed significant weight loss after a year compared with those on a competing dr...READ MORE